Companies Investors People

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

Contact
Request a Demo
Request Data Updates
Add a Company

Research

Companies
Investors
People

aVenture

Download App
Pricing
Alternatives

Resources

Documentation
Use Cases
CLI
MCP
Sitemap

aVenture is an AI-native agentic deep research tool for researching and finding companies and people, and is a high-quality alternative to AlphaSense, CB Insights, Crunchbase, Harmonic, Owler, Perplexity Finance, PitchBook, Preqin, PrivCo, Synaptic, and Tracxn.

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Pearl Therapeutics - aVenture Company Research

Pearl Therapeutics

Pearl Therapeutics

Acquired, subsidiary ofAstraZeneca

Pearl Therapeutics develops advanced respiratory treatments, focusing on dual/triple combo products for widespread diseases.

Redwood City, CA, US🇺🇸

Founded

Pearl Therapeutics develops advanced respiratory treatments, focusing on dual and triple combination products for chronic obstructive pulmonary disease. The company aims to make these therapies accessible to broad patient populations through familiar metered dose inhalers. Led by a team of respiratory product development experts, Pearl Therapeutics is committed to offering innovative solutions to patients and healthcare providers.

Pearl Therapeutics has made significant strides in the respiratory treatment market, gaining recognition for its innovative approach to combination therapies. The company's products have the potential to improve the quality of life for millions of patients with respiratory diseases. Pearl Therapeutics' impact is bolstered by its expert leadership and commitment to advancing inhaled therapies.

Pearl Therapeutics - M & A Snapshot

AstraZeneca
Acquired Pearl Therapeutics • Undisclosed • Jun 10, 2013

Pearl Therapeutics - Quick Facts

Who are Pearl Therapeutics' competitors?

Companies similar to Pearl Therapeutics include Respira Therapeutics, Respirics, Metera Pharmaceuticals and Aer Therapeutics.

When was Pearl Therapeutics founded?

Pearl Therapeutics was founded in 2006.

Where is Pearl Therapeutics' headquarters located?

Pearl Therapeutics' headquarters is located in Redwood City, CA, US.

How much disclosed funding has Pearl Therapeutics raised?

As of Jun 10, 2013, Pearl Therapeutics has disclosed funding of $255.5M (USD). Undisclosed round amounts are excluded.

Pearl Therapeutics - Classification

Industry: Professional Service Companies
Ownership: Private
Technology: Analytics
Geographic Exposure: Global

Revenue: Recurring
Software
Customer: Consumers
Enterprise
Main Product: Combination Products
Respiratory Treatments

Tags: Biotech
Healthtech

NAICS: 320000Manufacturing
325400Pharmaceutical and Medicine Manufacturing
325000Chemical Manufacturing
325410Pharmaceutical and Medicine Manufacturing
325412Pharmaceutical Preparation Manufacturing
SIC: 2800Chemicals And Allied Products
2830Drugs
2834Pharmaceutical Preparations

Show 18 more industry codes

Pearl Therapeutics - Similar Companies

Respira Therapeutics

Respirics

Metera Pharmaceuticals

Aer Therapeutics

Pulmatrix

pulmatrix.com

Kinaset Therapeutics

kinasettx.com

Pneuma Respiratory

Aerami Therapeutics

aerami.com

Theron Pharmaceuticals

Axikin Pharmaceuticals

axikin.com

InCarda Therapeutics

Parion Sciences

parion.com

Cardeas Pharma

Lung Biotechnology

unither.com

Aero Therapeutics

NAICS: 540000Professional, Scientific, and Technical Services
541200Accounting, Tax Preparation, Bookkeeping, and Payroll Services
541210Accounting, Tax Preparation, Bookkeeping, and Payroll Services
541219Other Accounting Services
541714Research and Development in Biotechnology (except Nanobiotechnology)
620000Health Care and Social Assistance
541000Professional, Scientific, and Technical Services
623000Nursing and Residential Care Facilities
541700Scientific Research and Development Services
541710Research and Development in the Physical, Engineering, and Life Sciences
SIC: 8720Accounting, Auditing, And Bookkeeping Services
8721Accounting, Auditing, and Bookkeeping Services
8000Health Services
8700Engineering, Accounting, Research, Management, And Related Services
8040Offices And Clinics Of Other Health Practitioners
8730Research, Development, And Testing Services
8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
8731Commercial Physical and Biological Research